Drug Topics September 27, 2024
Check out these important FDA updates from the month of September 2024.
FDA Approves Dupixent as First Biologic Treatment for COPD
he FDA has approved dupilumab (Dupixent) as an add-on maintenance treatment for adult patients with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype, Sanofi announced in a release. The decision makes dupilumab the first biologic medicine approved in the United States to treat the lung disease.
Schizophrenia Drug Approved by FDA Represents First New Treatment Option in Decades
The FDA approved xanomeline and trospium chloride (Cobenfy, formerly KarXT), an oral medication for the treatment of schizophrenia in adults, Bristol Myers Squibb announced in a release. The approval marks a breakthrough in the treatment for the condition,...
Today's Sponsors
Today's Sponsor